A few years ago I wrote a piece on those weird pharmaceutical names and their overwhelming advertising on TV – those “ask ...

The Trump administration is cracking down on pharmaceutical advertising—but stopped short of the worst-case scenario some drug and ad executives feared. The moves could dent, but not demolish, the ...

Bayer received an FDA Untitled Letter this week for its prostate cancer drug Nubeqa, shortly after it launched a lawsuit ...

The pair will integrate real-time diagnostic data into marketing workflows, with the aim of helping pharmaceutical companies ...

Is RYTM a good stock to buy? We came across a bearish thesis on Rhythm Pharmaceuticals, Inc. on BioEquity Watch’s Substack.

SHANGHAI, April 9 (Reuters) - China has removed all medical advertisements ‌on national TV channels containing false claims as of the end of ⁠March, the country's National Radio and Television ...

Regulators claim Pfizer’s ads created a misleading impression by describing Adcetris as a treatment for broader T-cell lymphoma populations than those covered by its FDA-approved label. The FDA also ...

Breaking news and analysis from time.com. Politics, world news, photos, video, tech reviews, health, science, and ...

Industry Leaders lists, an expansion of the TIME100 Most Influential Companies issue that dives deeper into 20 sectors to ...

Share on Pinterest A recent study found that social media influencers who promote prescription drugs may often share misleading information. Image Credit: Lucas Ottone/Stocksy A recent review suggests ...

Voucher application details focus on AUD as a major driver of the U.S. substance use crisis and the genetic targeting of AD04 ...